Research output per year
Research output per year
Research output
Search results
-
2023
A MACHINE LEARNING MODEL FOR IDENTIFYING IMPORTANT CLINICAL VARIABLES AND PREDICTING ONE-YEAR TREATMENT RETENTION IN PATIENTS WITH RHEUMATOID ARTHRITIS PERFORMING AN INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCH
Prenga, N., Nabi, H., Krogh, N. S., Akkoc, A., Hetland, M. L. & Glintborg, B., 2023, p. Annals of the rheumatic diseases, vol. 82 suppl. 1, page 494.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
DOES A MANDATORY SWITCH FROM ORIGINATOR ADALIMUMAB TO BIOSIMILAR GP2017 OR SB5 LEAD TO INCREASED HOSPITAL COSTS? A DANBIO STUDY OF >1,300 PATIENTS WITH INFLAMMATORY ARTHRITIS
Nabi, H., Ibsen, R., Ibsen, M., Kjellberg, J., Hetland, M. L. & Glintborg, B., 2023, p. Annals of the rheumatic diseases, vol. 82, suppl. 1, page 441.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
2022
Biosimilar-to-Biosimilar Switching in Routine Care – Results on >1,600 Patients with Inflammatory Arthritis in the DANBIO Registry
Nabi, H., Hendricks, O., Jensen, D. V., Loft, A. G., Pedersen, J., Just, S. A., Danebod, K., Munk, H. L., Kristensen, S., Manilo, N., Colic, A., Linauskas, A., Thygesen, P. H., Christensen, L., Kalisz, M. H., Lomborg, N., Chrysidis, S., Raun, J. L., Andersen, M. & Mehnert, F. & 3 others, , 2022, p. Arthritis & Reumatology Vol. 74, number S9, p. 2209.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry
Nabi, H., Hendricks, O., Jensen, D. V., Loft, A. G., Pedersen, J. K., Just, S. A., Danebod, K., Munk, H. L., Kristensen, S., Manilo, N., Colic, A., Linauskas, A., Thygesen, P. H., Christensen, L. B., Kalisz, M. H., Lomborg, N., Chrysidis, S., Raun, J. L., Andersen, M. & Mehnert, F. & 3 others, , Nov 2022, In: RMD Open. 8, 2, 002560.Research output: Contribution to journal › Journal article › Research › peer-review
-
2021
Biosimilar to biosimilar infliximab switching in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry: Switch from originator infliximab to CT-P13 and then to GP1111
Nabi, H., Glintborg, B., Loft, A., Hendricks, O., Pedersen, J., Just, S., Ahmed, R., Danebod, K., Munk, H., Colic, A., Linauskas, A., Jensen, D. V., Raun, J., Grydehøj, J., Christensen, L., Manilo, N., Lomborg, N., Kristensen, S., Mehnert, F. & Krogh, N. & 1 others, , 2021, In: Arthritis and Rheumatology. 73, No. S9, p. 1161-3 3 p., 0573.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial
Nabi, H., Georgiadis, S., Loft, A. G., Hendricks, O., Jensen, D. V., Andersen, M., Chrysidis, S., Colic, A., Danebod, K., Hussein, M. R., Kalisz, M. H., Kristensen, S., Lomborg, N., Manilo, N., Munk, H. L., Pedersen, J. K., Raun, J. L., Mehnert, F., Krogh, N. S. & Hetland, M. L. & 1 others, , Nov 2021, In: Annals of the Rheumatic Diseases. 80, 11, p. 1400-1409 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Initiation of and persistence with P2Y12 inhibitors in patients with myocardial infarction according to revascularization strategy: a nationwide study
Tajchman, D. H., Nabi, H., Aslam, M., Butt, J. H., Grove, E. L., Engstrøm, T., Holmvang, L., Fosbøl, E. L., Køber, L. & Sørensen, R., Sept 2021, In: European heart journal. Acute cardiovascular care. 10, 7, p. 774-786 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Multiple infliximab biosimilar switches: Results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111, in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry
Nabi, H., Glintborg, B., Loft, A., Hendricks, O., Pedersen, J., Just, S., Ahmed, R., Danebod, K., Munk, H., Colic, A., Linauskas, A., Jensen, D. V., Christensen, L., Manilo, N., Lomborg, N., Kristensen, S., Mehnert, F., Krogh, N. & Hetland, M. L., 2021, In: Scandinavian Journal of Rheumatology, Supplement. 50, 130, p. 14-5 2 p., OP16.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
2020
Antithrombotic treatment and major adverse cardiac events after bleeding in patients with myocardial infarction: a retrospective analysis of nationwide registry data
Nabi, H., Rørth, R., Tajchman , D. H., Holmvang, L., Torp-Pedersen, C., Gislason, G., Fosbøl, E. L., Køber, L. & Sørensen, R., 1 Jan 2020, In: European heart journal. Cardiovascular pharmacotherapy. 6, 1, p. 14-21 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
4 Citations (Scopus)